KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Gilead Sciences' Shares Outstanding (Diluted Average) rose 15.95% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 15.95%. This contributed to the annual value of $1.3 billion for FY2024, which is 23.85% down from last year.
  • As of Q3 2025, Gilead Sciences' Shares Outstanding (Diluted Average) stood at $1.3 billion, which was up 15.95% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Shares Outstanding (Diluted Average) ranged from a high of $1.3 billion in Q1 2021 and a low of $1.2 billion during Q1 2024
  • In the last 5 years, Gilead Sciences' Shares Outstanding (Diluted Average) had a median value of $1.3 billion in 2023 and averaged $1.3 billion.
  • In the last 5 years, Gilead Sciences' Shares Outstanding (Diluted Average) plummeted by 111.02% in 2024 and then surged by 96.23% in 2025.
  • Over the past 5 years, Gilead Sciences' Shares Outstanding (Diluted Average) (Quarter) stood at $1.3 billion in 2021, then changed by 0.0% to $1.3 billion in 2022, then dropped by 0.32% to $1.3 billion in 2023, then fell by 0.24% to $1.3 billion in 2024, then rose by 0.08% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.